AcelRx Pharma (ACRX) Reports Q1 Loss of $0.23

AcelRx Pharma (NASDAQ: ACRX) reported Q1 EPS of ($0.23), versus ($0.34) reported last year. Revenue for the quarter came in at $343 million, versus $3.11 billion reported last year.

For earnings history and earnings-related data on AcelRx Pharma (ACRX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance